Primary |
Hypercholesterolaemia |
17.8% |
Blood Cholesterol Increased |
17.1% |
Hypertension |
13.7% |
Hyperlipidaemia |
10.3% |
Acute Coronary Syndrome |
5.1% |
Myocardial Ischaemia |
4.3% |
Diabetes Mellitus |
4.1% |
Blood Cholesterol |
3.8% |
Coronary Artery Disease |
3.6% |
Type 2 Diabetes Mellitus |
2.6% |
Cardiovascular Event Prophylaxis |
2.2% |
Dyslipidaemia |
2.1% |
Prophylaxis |
2.1% |
Atrial Fibrillation |
1.8% |
Product Used For Unknown Indication |
1.7% |
Depression |
1.7% |
Angina Pectoris |
1.7% |
Myocardial Infarction |
1.6% |
Hypothyroidism |
1.5% |
Pain |
1.1% |
|
Rhabdomyolysis |
37.8% |
Myalgia |
14.9% |
Pain In Extremity |
6.4% |
Myopathy |
3.6% |
Muscle Spasms |
3.5% |
Myositis |
3.1% |
Muscular Weakness |
3.0% |
Pain |
3.0% |
Vomiting |
3.0% |
Myocardial Infarction |
2.7% |
Renal Failure Acute |
2.7% |
Weight Decreased |
2.5% |
Drug Interaction |
2.3% |
Wrong Technique In Drug Usage Process |
2.0% |
Renal Failure |
1.9% |
Blood Creatine Phosphokinase Increased |
1.6% |
Tendon Rupture |
1.6% |
Drug Hypersensitivity |
1.5% |
Cerebrovascular Accident |
1.4% |
Drug Ineffective |
1.3% |
|
Secondary |
Blood Cholesterol Increased |
17.5% |
Hypercholesterolaemia |
13.2% |
Product Used For Unknown Indication |
12.5% |
Hypertension |
11.2% |
Drug Use For Unknown Indication |
9.9% |
Hyperlipidaemia |
6.7% |
Coronary Artery Disease |
3.5% |
Myocardial Ischaemia |
3.5% |
Diabetes Mellitus |
3.4% |
Type 2 Diabetes Mellitus |
3.1% |
Blood Cholesterol |
2.7% |
Depression |
1.9% |
Cardiac Disorder |
1.9% |
Pain |
1.5% |
Atrial Fibrillation |
1.4% |
Cardiovascular Event Prophylaxis |
1.3% |
Myocardial Infarction |
1.3% |
Prophylaxis |
1.2% |
Blood Triglycerides Increased |
1.2% |
Ill-defined Disorder |
1.2% |
|
Rhabdomyolysis |
22.4% |
Myalgia |
12.8% |
Drug Hypersensitivity |
7.1% |
Pain In Extremity |
6.9% |
Wrong Technique In Drug Usage Process |
5.9% |
Vomiting |
5.4% |
Weight Decreased |
4.5% |
Pain |
4.0% |
Muscle Spasms |
3.8% |
Weight Increased |
3.2% |
Myopathy |
3.1% |
Pulmonary Embolism |
3.0% |
Myocardial Infarction |
2.7% |
Muscular Weakness |
2.6% |
Myositis |
2.5% |
Renal Failure Acute |
2.4% |
Pancreatitis |
2.3% |
Blood Creatine Phosphokinase Increased |
2.0% |
Nausea |
1.9% |
Overdose |
1.8% |
|
Concomitant |
Product Used For Unknown Indication |
23.6% |
Drug Use For Unknown Indication |
15.5% |
Hypertension |
10.7% |
Blood Cholesterol Increased |
6.0% |
Diabetes Mellitus |
5.5% |
Depression |
4.3% |
Pain |
4.3% |
Osteoporosis |
3.3% |
Rheumatoid Arthritis |
3.2% |
Type 2 Diabetes Mellitus |
3.0% |
Gastrooesophageal Reflux Disease |
2.8% |
Atrial Fibrillation |
2.6% |
Anxiety |
2.1% |
Blood Cholesterol |
2.0% |
Arthritis |
2.0% |
Cardiac Disorder |
2.0% |
Chronic Obstructive Pulmonary Disease |
1.9% |
Prophylaxis |
1.8% |
Blood Pressure |
1.8% |
Multiple Myeloma |
1.6% |
|
Weight Decreased |
11.2% |
Myocardial Infarction |
10.9% |
Vomiting |
10.7% |
Weight Increased |
8.2% |
Nausea |
6.0% |
Drug Ineffective |
5.2% |
Pain |
4.8% |
Type 2 Diabetes Mellitus |
4.3% |
Vision Blurred |
4.3% |
Death |
4.1% |
Urinary Tract Infection |
3.7% |
Renal Failure |
3.2% |
Dyspnoea |
3.2% |
Flushing |
3.1% |
Transient Ischaemic Attack |
2.9% |
Tremor |
2.9% |
Pneumonia |
2.9% |
Somnolence |
2.9% |
Cerebrovascular Accident |
2.8% |
Syncope |
2.7% |
|
Interacting |
Drug Use For Unknown Indication |
19.7% |
Product Used For Unknown Indication |
15.6% |
Hypertension |
8.2% |
Hiv Infection |
6.6% |
Hyperlipidaemia |
6.6% |
Blood Cholesterol Increased |
4.9% |
Blood Cholesterol |
4.1% |
Diabetes Mellitus |
4.1% |
Hypercholesterolaemia |
4.1% |
Asthma |
3.3% |
Dyslipidaemia |
3.3% |
Blood Cholesterol Abnormal |
2.5% |
Depression |
2.5% |
Heart Transplant |
2.5% |
Hypersensitivity |
2.5% |
Lipids |
2.5% |
Prophylaxis |
2.5% |
Abstains From Alcohol |
1.6% |
Arteriosclerosis |
1.6% |
Atrioventricular Block |
1.6% |
|
Rhabdomyolysis |
29.1% |
Drug Interaction |
12.7% |
Jaundice |
5.5% |
Myalgia |
5.5% |
Drug Ineffective |
3.6% |
Feeling Abnormal |
3.6% |
Haematoma |
3.6% |
International Normalised Ratio Increased |
3.6% |
Thrombophlebitis Superficial |
3.6% |
Tricuspid Valve Incompetence |
3.6% |
Upper Limb Fracture |
3.6% |
Visual Disturbance |
3.6% |
Vitamin B1 Increased |
3.6% |
Vomiting |
3.6% |
Aspartate Aminotransferase Increased |
1.8% |
Asthenia |
1.8% |
Back Pain |
1.8% |
Blood Creatine Phosphokinase Increased |
1.8% |
Discomfort |
1.8% |
Drug Dose Omission |
1.8% |
|